M/phmtrc alysishquant/semiq
CPT 88369 covers advanced computer-assisted analysis of tissue samples to measure specific cellular features like tumor markers, nuclear size, or protein distribution. This quantitative measurement helps pathologists make more precise diagnoses.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Document the specific morphometric parameters measured (e.g., nuclear area, staining intensity scores, cell counts per high-power field) and the computer system used
Impact: Prevents denials for insufficient documentation; essential for medical necessity support and can prevent $126.80 denial per claim
Clearly distinguish 88369 from fully automated analysis codes by documenting the pathologist's manual review, interpretation, and quantitative correlation with histologic findings
Impact: 88369 requires professional interpretation component; lack of documentation may result in downcoding to lower-paying automated testing codes, reducing payment by $50-80
Bill 88369 separately from the parent specimen examination code (e.g., 88305, 88307) as it represents additional quantitative analysis beyond routine microscopy
Impact: Failure to bill separately leaves $126.80 on the table; this is an add-on analytic service to base pathology examination
When performing multiple morphometric analyses on the same specimen for different markers, append modifier 59 to subsequent units and document distinct clinical purposes
Impact: Allows payment for each distinct analysis; properly documented multiple units can yield $253.60+ for two separate marker analyses
Verify LCD/LCA coverage requirements for your MAC as some payers require specific cancer diagnoses or treatment planning documentation for morphometric analysis coverage
Impact: Preemptive coverage verification prevents denials; some MACs restrict payment to specific ICD-10 codes, avoiding 100% claim denial
Report time-of-service diagnosis codes that justify quantitative analysis necessity, such as malignancies requiring prognostic marker quantification for treatment selection
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.